July 14, 2020
NYSDOH Requirements for Healthcare Personnel Returning to Work After COVID-19 Exposure or Infection
A NYSDOH advisory outlines updated requirements for healthcare personnel returning to work after COVID-19 exposure and/or infection.
July 14, 2020
A NYSDOH advisory outlines updated requirements for healthcare personnel returning to work after COVID-19 exposure and/or infection.
July 8, 2020
In an effort to mitigate the dual impact of COVID-19 and the seasonal flu, vaccine manufacturers are increasing influenza vaccine production by 10 percent this year.
July 2, 2020
The Centers for Disease Control and Prevention says additional age-related factors and underlying medical conditions increase an individual’s risk of severe COVID-19.
July 1, 2020
On July 10, MLMIC and MedPro Group will present a one-hour webinar with guidance and strategies for protecting medical practices while emerging from the COVID-19 pandemic.
June 23, 2020
A new risk prediction calculator, called the nomogram, can help physicians forecast a patient’s risk of testing positive for COVID-19, as well as the severity of the disease.
June 17, 2020
Amended guidance issued by the New York State Department of Health directs hospitals and healthcare facilities to test patients for COVID-19 five days prior to an elective surgery.
June 17, 2020
Based on the widespread impact of the COVID-19 pandemic, experts say healthcare organizations should consider four key changes to mitigate the effects of any future large-scale disruptions.
June 16, 2020
The Joint Commission shares important considerations and guidance related to mental health problems among healthcare professionals caused by the COVID-19 pandemic.
June 10, 2020
Due to high COVID-19 rates in nursing homes, CMS says it will increase enforcement for facilities with persistent infection control violations and impose enforcement actions for lower level infection control deficiencies.
June 8, 2020
Recent statements issued by the New England Journal of Medicine and the Lancet share significant concern related to the credibility of two major studies evaluating the safety and efficacy of hydroxychloroquine to prevent and treat COVID-19.